Vertex Pharmaceuticals Incorporated

Financials

Overview Estratto Conto Statistics Dividends

Cash from operating activities 3.25 B2.64 B4.13 B3.54 B492.6 M3.63 B 3.63 B Cash from investing activities 99.39 M340.9 M321.1 M3.14 B3.77 B945.4 M 945.4 M Cash from financing activities 505.28 M1.48 B67.7 M562.2 M1.49 B2.26 B 2.26 B Free cash flow 2.99 B2.41 B3.93 B3.28 B194.9 M3.19 B 3.19 B

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

VRTX

Financials

Vertex Pharmaceuticals Incorporated

Notizie

Stock Market Today: Dow Slumps 700 Points On Inflation Data; Nvidia Partner CoreWeave Plunges (Live Coverage)

Ambrose, SVP di Vertex Pharmaceuticals, vende azioni VRTX per 108.000$

Ambrose, Vertex Pharmaceuticals SVP, sells $108k in VRTX stock

EVP di Vertex Pharmaceuticals Tatsis vende azioni per 126.000$

Vertex Pharmaceuticals EVP Tatsis sells $126k in stock

L’EVP di Vertex Pharmaceuticals Sachdev vende azioni per 897k$

Vertex Pharmaceuticals EVP Sachdev sells $897k in shares

EVP di Vertex Pharma McKechnie vende azioni per 2,39 milioni di dollari

Vertex Pharma EVP McKechnie sells $2.39m in shares

ARK di Cathie Wood vende azioni PagerDuty, acquista Tempus AI

Electromed Stock: How Far Can This Microcap Go Before Their Market Collapses? (NYSE:ELMD)

BB Biotech FY 2025: utili +660%, outlook 2026 cauto